The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain

International Journal of Obesity

Volumn 31, Issue 3, 2007, Pages 481-487

  Watras, A C ^a   Buchholz, A C ^b   Close, R N ^a   Zhang, Z ^a   Schoeller, D A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Body composition; Body weight; CLA; Four compartment model; Overweight

Indexed keywords

CONJUGATED LINOLEIC ACID;

ABDOMINAL FAT; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CALORIMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON COLD SYMPTOM; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFICACY; DRUG SAFETY; ENERGY EXPENDITURE; FEMALE; HUMAN; INFLUENZA; LIPID BLOOD LEVEL; MALE; METABOLIC RATE; OBESITY; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TOTAL BODY WATER; UNITED STATES; WEIGHT GAIN;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BODY COMPOSITION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HOLIDAYS; HUMANS; LINOLEIC ACIDS, CONJUGATED; LIVER FUNCTION TESTS; MALE; OBESITY; PATIENT COMPLIANCE; SEASONS; WEIGHT GAIN;

ANIMALIA;

EID: 33847324492     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803437     Document Type: Article

References (33)

1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291: 2847-2850.
2. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998; 68: 899-917.
3. Pariza MW. Perspective on the safety and effectiveness of conjugated linoleic acid. Am J Clin Nutr 2004; 79: 1132S-1136S.
4. Wang YW, Jones PJ. Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 2004; 28: 941-955.
5. Terpstra AH. Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature. Am J Clin Nutr 2004; 79: 352-361.
6. Wahle KW, Heys SD, Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health? Prog Lipid Res 2004; 43: 553-587.
7. Atkinson RL. Conjugated linoleic acid for altering body composition and treating obesity. Advances in conjugated linoleic acid research, volume 1. In: Yurawecz MP, Mossoba MM, Kramer JKG, Pariza MW, Nelson GJ (eds). AOCS Press: Champagne, IL, 1999. pp. 348-353.
8. Berven G, Bye A, Hals O. Safety of conjugated linoleic acid (CLA) in overweight or obese volunteers. Eur J Lipid Sci Technol 2000; 102: 455-462.
9. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 2000; 130: 2943-2948.
10. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H et al. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 2005; 135: 778-784.
11. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 2004; 79: 1118-1125.
12. Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 2003; 27: 840-847.
13. Whigham LD, O'Shea M, Mohede IC, Walaski HP, Atkinson RL. Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. Food Chem Toxicol 2004; 42: 1701-1709.
14. Yanovski JA, Yanovski SZ, Sovik KN, Nguyen TT, O'Neil PM, Sebring NG. A prospective study of holiday weight gain. N Engl J Med 2000; 342: 861-867.
15. Bartok-Olson CJ, Schoeller DA, Sullivan JC, Clark RR. The 'B' in the Selinger Four-Compartment body composition formula should be body mineral instead of bone mineral. Ann NY Acad Sci 2000; 904: 342-344.
16. Behnke A, Wilmore J. Evaluation and Regulation of Body Build and Composition. Prentice-Hall: Englewood Cliffs, NJ, 1974.
17. Wilmore H. A simplified method for determination of residual lung volumes. J Appl Physiol 1969; 27: 98-100.
18. 2 samples by continuous-flow isotope ratio mass spectrometry. J Mass Spec 1997; 32: 1332-1336.
19. Schoeller D. Hydrometry. In: Heymsfield S, Lohman T, Wang Z, Going S (eds). Human Body Composition. Human Kinetics: Champagne, IL, 2005. pp 35-49.
20. Heymsfield S, Lichtman S, Baumgartner R, Wang J, Kamen Y, Aliprantis A et al. Body composition of humans: comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure. Am J Clin Nutr 1990; 52: 52-58.
21. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949; 109: 1-9.
22. Sallis J. Seven day physical activity recall. Med Sci Sports Exerc 1997; 29: S89-S103.
23. Conwell LS, Trost SG, Brown WJ, Batch JA. Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 2004; 27: 314-319.
24. Sun G, French CR, Martin GR, Younghusband B, Green RC, Xie YG et al. Comparison of multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am J Clin Nutr 2005; 81: 74-78.
25. Larsen TM, Toubro S, Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 2003; 44: 2234-2241.
26. Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002; 25: 1516-1521.
27. Eyjolfson V, Spriet LL, Dyck DJ. Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Med Sci Sports Exerc 2004; 36: 814-820.
28. Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr 2004; 80: 257-263.
29. Malpuech-Brugere C, Verboeket-van de Venne WP, Mensink RP, Arnal MA, Morio B, Brandolini M et al. Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res 2004; 12: 591-598.
30. Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005; 135: 562-566.
31. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans - metabolic effects. Lipids 2001; 36: 773-781.
32. Schulz LO, Schoeller DA. A compilation of total daily energy expenditures and body weights in healthy adults. Am J Clin Nutr 1994; 60: 676-681.
33. Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, Bingham S et al. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol 2003; 158: 1-13.